Healwell Ai Inc. Stock

-          HEALWELL’s current goal is to achieve run rate revenues approaching $100 million by the end of the year from

-          WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients

-          HEALWELL is pleased to provide an update on its improved balance sheet with the reduction of approximately $15.5 million of

-          HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma

-          HEALWELL completes USD $2,000,000 strategic investment into an xAI investment vehicle as part of its capital allocation strategy where it seeks to enhance and accelerate the

-          Pentavere collaborated with Princess Margaret Cancer Centre’s Radiation Oncology Department to

-          HEALWELL has entered into an agreement to acquire BioPharma Services Inc., one of the largest full-service

-          HEALWELL enters into an agreement to acquire VeroSource Solutions Inc. and its end-to-end, customizable, cloud-based platform that enables patients, care providers and

-          Pentavere’s partnership with Takeda to pioneer real-world evidence analysis for HAE patients, addressing critical gaps in treatment understanding.

-          This innovative

-          Experienced finance and technology executive Anthony Lam joins as the Company’s new Chief Financial Officer.

-          Mr. Lam will replace Mr. Scott Nirenberski who has been

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, ONTARIO - May 22, 2024 - HEALWELL AI INC. (“HEALWELL” or the “Company”) (TSX: AIDX) is

HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinician Co-pilot System Can Improve Cancer Staging in Prestigious Peer-Reviewed Medical Journal

-          HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”)

-          HEALWELL AI achieved quarterly revenue from continuing operations of $4.58 million in Q1-2024, 132%

-          WELL and HEALWELL AI have launched the second-generation of WELL AI Decision Support (“WAIDS”), which now features advanced chronic disease screening for diseases like chronic

-          Pentavere has published industry’s first peer-reviewed paper utilizing AI and large language models (or LLMs) to identify rare lung cancer patients.

-          Industry

-          HEALWELL AI achieved annual revenue from continuing operations of $7.32 million in fiscal 2023. HEALWELL ended 2023 with

-          Intrahealth is pleased to report on a recent customer implementation with Toronto Public Health, a health unit responsible for delivering public health programs and services,

-          HEALWELL AI has signed services agreements with both WELL Health USA and U.S. based Circle Medical Technologies Inc., which expands its footprint in the U.S. and will enable U.S.

-          Hamed Shahbazi, Founder, Chairman and CEO of WELL Health Technologies has been appointed Chairman of HEALWELL AI, a global leader in AI powered preventative care.

-          Mr.

-          Intrahealth is pleased to report on a recent enterprise customer installation at the Canuck Place Children’s Hospice in Vancouver, BC. Intrahealth’s Profile EHR will serve as the

-          Pentavere continues to publish ground-breaking AI work accepted at prestigious global medical conferences and leading oncology organizations. In the past quarter Pentavere

-          HEALWELL has completed the previously announced acquisition of Intrahealth, a SaaS based enterprise class multi-national EHR (Electronic Health Record) provider supporting

-          HEALWELL enters into agreement to acquire Intrahealth, a SaaS based enterprise class multi-national EHR (Electronic Health Record) provider supporting approximately 15,000